WELLTOWER INC.
Last · NYSE$232.25+2.11 (+0.92%)close · yahoo · 13h ago
Vol 3.26M ≈ 756.41M
MA10MA20MA50
Market cap$167.35B720.6M sh
P/E · TTM104fwd 73.0 · eps 2.23
Beta0.75vs S&P 500
Div yield1.33%annual · TTM
52w range
$168.83$255.20
Volume1.5Msession
Issuer
Legal nameWELLTOWER INC.
HQUnited States (US)
ListingUS WELL
ISINUS95040Q1040
SectorReal Estate
IndustryR.E.I.T.
SIC6798
CurrencyUSD
Entity registrysec:0000766704
CIK0000766704
Websitewww.welltower.com
Employees712
AddressWelltower OP LLC 4500 Dorr Street 43615, Toledo
| Revenue | $12.8B |
|---|---|
| Net income | $1.6B |
| Free cash flow | $2.4B |
| Net margin | 12.1% |
| Return on equity | 3.3% |
| Period | TTM 2026-06-30 |
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-02-12
From latest 10-K · 2026-02-12
- Senior Housing
- Operator Concentration
- Debt Refinancing
- Equity Dilution
- Medicaid Reimbursement
- Labor Costs
- Genesis Credit Risk
- Construction Commitments
Red flags
- Dilution was substantial: 61.2 million shares were issued in 2025, including 56.1 million ATM shares at an average $159.47; outstanding shares rose to 696.5 million from 635.3 million, approximately 9.6%.
- Debt totaled $19.20 billion at carrying value, with $5.21 billion of scheduled principal maturities in 2026-2027 and $6.18 billion of gross property value securing secured debt.
- NOI concentration is meaningful: the top five relationships contributed 27% of 2025 NOI; Cogir alone represented 8%, while Care UK represented 5% and generated $1.17 billion of revenue from managed properties.
- Loan exposure is expanding: net cash advances on loans receivable were $469.0 million in 2025, and total loans receivable reached $2.08 billion, including $125.0 million of deteriorated loans before the Genesis-related disclosure detail.
- Reported stock-based compensation was $1.56 billion in 2025, including $1.41 billion tied to Executive & Key Employee LTIP awards; this is a substantial non-cash expense and complicates interpretation of reported earnings and dilution.
Upcoming earnings
MON.26OCT
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
$0.63
Est. revenue
3.8B
Earnings transcripts
- Issuer webcast
A replay of the webcast is available here
WELL HEALTH TECHNOLOGIES CORP.
- Issuer webcast
Click here to join the webcast
WELL HEALTH TECHNOLOGIES CORP.
- Issuer webcast
Click here to join the webcast
WELL HEALTH TECHNOLOGIES CORP.
- Issuer webcast
Click here to join the webcast
WELL HEALTH TECHNOLOGIES CORP.
- Issuer webcast
Click here to join the webcast
WELL HEALTH TECHNOLOGIES CORP.
- Issuer webcast
Click here to join the webcast
WELL HEALTH TECHNOLOGIES CORP.
Documents
FormReporting forFiledFlags
Showing 5 of 404 filings